ABSTRACT
Aim: In oncology, thermal therapy is the application of external heat to fight cancer cells. The goal of whole-body thermal treatment (WBTT) is to raise the patient's core temperature to 39-42 °C, and represents the only thermal treatment modality that can act on both the primary tumor and distant metastases. However, WBTT carries potential risks for toxicity when applied without accurate thermometry and monitoring.Methods: ElmediX has developed a medical device, HyperTherm, to deliver long-term controlled and accurate WBTT (41.5 °C, up to 8 h). The safety of the device and thermal treatment protocol was initially evaluated in minipigs, and we present the confirmation of tolerability of WBTT in dogs with advanced cancer, in combination with a reduced dose of radiotherapy or chemotherapy.Results: Thermometry in liver, rectum, and tumor confirmed a homogeneous heating of these body parts. Monitoring of clinical parameters showed acceptable and reversible changes in liver, cardiac, muscle and coagulation parameters, as was expected. Combination of WBTT with both radiotherapy and chemotherapy only caused some low-grade adverse events.Conclusion: We conclude that our findings support the safe use of HyperTherm-mediated WBTT for canine patients with advanced malignancies. They also tend to support a genuine therapeutic potential for long-term WBTT which needs to be confirmed on a larger dog patient population. Combined with previously reported safety results in minipigs, these contribute to support the ongoing clinical evaluation of WBTT in advanced human cancer patients.
Subject(s)
Hyperthermia, Induced , Neoplasms , Animals , Combined Modality Therapy , Dogs , Human Body , Humans , Hyperthermia, Induced/methods , Neoplasms/radiotherapy , Swine , Swine, Miniature , TemperatureABSTRACT
Spinal cord stimulation is a minimally invasive mode of treatment in the management of certain forms of chronic pain that do not respond to conventional pain therapy. Several authors have reported encouraging findings with this technique. Over a 10-year period in a single centre, 254 patients were subjected to a trial period of spinal cord stimulation with an externalized pulse generator. Two hundred and seventeen of the patients showed satisfactory results justifying permanent implantation of a spinal cord stimulation system. In 1998, an independent physician invited 153 patients (155 pain cases), who still had the system in place and who could be contacted, for an interview. The aim of this study was to evaluate the efficacy of an implanted spinal cord stimulation system in terms of pain relief and quality of life and to assess the accuracy of the patient selection criteria. The results of this study demonstrate a high success rate as evaluated by the patients' own assessments--68% of the patients rated the result of the treatment as excellent to good after an average follow-up of almost 4 years. The resumption of work by 31% of patients who had been working before the onset of pain supports these positive findings.
Subject(s)
Electric Stimulation Therapy/statistics & numerical data , Pain Clinics/statistics & numerical data , Pain Management , Pain/psychology , Spinal Cord/surgery , Adult , Aged , Aged, 80 and over , Analgesics/therapeutic use , Belgium , Electric Stimulation Therapy/adverse effects , Electric Stimulation Therapy/instrumentation , Electrodes/standards , Female , Humans , Male , Middle Aged , Occupational Diseases/etiology , Pain/physiopathology , Pain Clinics/trends , Pain Measurement/methods , Patient Acceptance of Health Care/statistics & numerical data , Patient Selection , Quality of Life/psychology , Sleep Wake Disorders/etiology , Sleep Wake Disorders/physiopathology , Spinal Cord/physiopathology , Treatment OutcomeABSTRACT
Spinally administered opioids must be a last step in the therapeutical arsenal of chronic benigne pain. It is an invasive technique not free from adverse effects. Two chronic pain patients received an implantable Synchromed pump for treatment with spinal opiates after a trial period of resp. 3.5 and 5.5 months. Due to a misprogrammation (both on the same day) they received very high doses of spinal opiates. This caused relatively few side effects, which did not seem to require immediate treatment. A short time development of tolerance to life threatening side-effects has been proven by this accidental administration of high-dose intraspinal opiates. It is critical that care providers are knowledgeable and well-trained about implantable infusion systems. Programmation and refills must always be performed with care.
Subject(s)
Analgesics, Opioid/poisoning , Equipment Failure , Infusion Pumps , Morphine/poisoning , Aged , Analgesics, Opioid/administration & dosage , Analgesics, Opioid/therapeutic use , Female , Humans , Hypophosphatemia, Familial/complications , Inflammation/drug therapy , Male , Middle Aged , Morphine/administration & dosage , Morphine/therapeutic use , Osteoporosis/complications , Pain, Intractable/drug therapy , Pelvic FloorABSTRACT
Topical anesthesia with intravenous sedation was used in 100 cases of phacoemulsification. Results show that this technique is a good and safe alternative for retrobulbar and peribulbar anesthesia.
Subject(s)
Anesthesia, Local/methods , Phacoemulsification , Aged , Aged, 80 and over , Ambulatory Surgical Procedures , Anesthetics, Local , Conscious Sedation , Humans , Middle Aged , Procaine/analogs & derivativesABSTRACT
In most medical textbooks, a mediastinoscopy is considered an absolute contraindication for a repeat mediastinoscopy. Retrospectively, perioperative data from 101 patients were evaluated in whom repeat mediastinoscopy was performed. The complication rate was 23% in 18 patients; 10% of these were directly related to the surgery. The surgical complications observed were hemorrhage, biopsy of the esophagus, paresis of a recurrent laryngeal nerve, and pneumothorax, which were all treated successfully. The patients receiving a nondepolarizing relaxant had fewer complications than patients given only a single dose of succinylcholine. In this patient population, the mortality rate was zero. This review concludes that an earlier mediastinoscopy is not necessarily an absolute contraindication for repeat mediastinoscopy.